TIGIT and melanoma: Of note, GIMAP7 mRNA expression displays impressive correlations with immune checkpoints PDL2, CD96, TIGIT, BTLA (Fig. 7d), other immune checkpoints in melanoma, and across 30 cancer types (Additional file 9: Fig S9a).